Alcon Inc ALC

Morningstar Rating
CHF 83.04 −0.94 (1.12%)
View Full Chart

Company Report

Price vs Fair Value

ALC is trading at a 569% premium.
Price
CHF 83.04
Fair Value
CHF 69.00
Uncertainty
Medium
1-Star Price
CHF 29.10
5-Star Price
CHF 79.60
Economic Moat
Ghhvztr
Capital Allocation
Rrbcpkjc

Bulls Say, Bears Say

Bulls

Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.

Bears

A failure to help doctors transition from Centurion to a new phacoemulsification machine (upon launch in the next two years) could leave some customers unsatisfied and moving to a different manufacturer.

News

Trading Information

Previous Close Price
CHF 83.98
Day Range
CHF 82.5683.70
52-Week Range
CHF 61.2885.34
Bid/Ask
CHF 82.50 / CHF 83.80
Market Cap
CHF 40.96 Bil
Volume/Avg
511,523 / 613,356

Key Statistics

Price/Earnings (Normalized)
29.79
Price/Sales
4.83
Dividend Yield (Trailing)
0.29%
Dividend Yield (Forward)
0.29%
Total Yield
0.29%

Company Profile

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
25,315

Competitors

Valuation

Metric
ALC
COO
AFX
Price/Earnings (Normalized)
29.7930.3230.03
Price/Book Value
2.182.692.86
Price/Sales
4.835.622.89
Price/Cash Flow
21.6422.5718.41
Price/Earnings
ALC
COO
AFX

Financial Strength

Metric
ALC
COO
AFX
Quick Ratio
1.380.882.34
Current Ratio
2.561.993.51
Interest Coverage
6.165.5812.08
Quick Ratio
ALC
COO
AFX

Profitability

Metric
ALC
COO
AFX
Return on Assets (Normalized)
4.81%3.02%
Return on Equity (Normalized)
6.86%4.67%
Return on Invested Capital (Normalized)
6.01%4.23%
Return on Assets
ALC
COO
AFX

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
NtryjscgnQpvwl$170.4 Bil
Becton Dickinson & Co
BDX
FbzymylqmZgjqs$68.6 Bil
Alcon Inc
ALC
CxnppfgbZcjvhl$48.7 Bil
ResMed Inc
RMD
DxwdvpghRkhdnc$35.0 Bil
Coloplast AS ADR
CLPBY
NrrdvnrdfqVbml$29.2 Bil
West Pharmaceutical Services Inc
WST
MkrzggnmdkWvrdw$21.6 Bil
The Cooper Companies Inc
COO
NrxwzqxVmgskk$21.3 Bil
Hologic Inc
HOLX
PphjtwpvKfqzft$18.4 Bil
Baxter International Inc
BAX
FjxxbjpzRprxy$17.9 Bil
Align Technology Inc
ALGN
ZfkjrbqmHjrjgj$17.7 Bil

Sponsor Center